BIOSYNTHESIS OF BACTERIAL CELL WALLS AND MEMBRANES
Project Number5R01AI005044-24
Contact PI/Project LeaderSHOCKMAN, GERALD D
Awardee OrganizationTEMPLE UNIV OF THE COMMONWEALTH
Description
Abstract Text
We will study aspects of the biosynthesis and assembly of bacterial cell surface
structures - the cell wall and membrane, in relationship to cellular growth and
cell division. Streptococcus faecalis ATCC 9790 (S. faecium) will be used as a
"model system", primarily because of its relatively simple shape and mode of
division. Future investigations will emphasize: 1. The roles of the autolytic
peptidoglycan hydrolase (an N-acetylmuramidase) in cell wall growth and
division. The autolytic enzyme will be isolated, purified to homogeniety and a
number of its properties will be studied. Interaction of highly purified enzyme
with known inhibitors of its activity such as lipoteichoic acids and
phospholipids will be studied. The kinetics of synthesis, and excretion of the
lipoteichoic acid inhibitor will be studied during both balanced and unbalanced
growth. 2. The isolation and study of the properties of conditional mutants
with defects in cell wall or membrane assembly, structure, synthesis or
function. Initial emphasis will be placed on mutants with defects in their
autolytic enzyme system. 3. Detailed studies of observed variations in rates of
peptidoglycan synthesis and capacity to autolyze of cells in various stages of
the cell division cycle. We will be particularly interested in the biochemical
and molecular mechanisms for regulation of autolytic activity during normal cell
division. 4. Studies of the relationship of autolytic enzyme activity to the
bactericidal action of penicillins and other antibiotics that inhibit cell wall
assembly. The sequence of reactions leading to cell death will be investigated
as will mechanisms by which streptomycin (and other aminoglycoside antibiotics)
and penicillins (and other inhibitors of cell wall assembly) act
synergistically.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
057123192
UEI
QD4MGHFDJKU1
Project Start Date
01-January-1978
Project End Date
31-March-1988
Budget Start Date
01-January-1987
Budget End Date
31-March-1988
Project Funding Information for 1987
Total Funding
$172,738
Direct Costs
$107,174
Indirect Costs
$65,564
Year
Funding IC
FY Total Cost by IC
1987
National Institute of Allergy and Infectious Diseases
$172,738
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI005044-24
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI005044-24
Patents
No Patents information available for 5R01AI005044-24
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI005044-24
Clinical Studies
No Clinical Studies information available for 5R01AI005044-24
News and More
Related News Releases
No news release information available for 5R01AI005044-24
History
No Historical information available for 5R01AI005044-24
Similar Projects
No Similar Projects information available for 5R01AI005044-24